Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 222 Carboplatin 215 Cisplatin 203 Paclitaxel 181 Gemcitabine 148 Docetaxel 126 Capecitabine 114 Cyclophosphamide 102 Pemetrexed 100 Dexamethasone 100 Specimen Handling 99 Magnetic Resonance Spectroscopy 97 Oxaliplatin 96 Radiotherapy 94 Doxorubicin 91 Fluorouracil 88 Bevacizumab 84 Leucovorin 73 Nivolumab 72 Rituximab 71 Vincristine 68 durvalumab 65 Lenalidomide 64 Radiation 62 atezolizumab 61 Irinotecan 61 Etoposide 60 130-nm albumin-bound paclitaxel 58 Prednisone 55 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Base Sequence × 1 year × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡